Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DS-1103a |
Trade Name | |
Synonyms | DS1103a|DS 1103a |
Drug Descriptions |
DS-1103a is an antibody that targets SIRPA and prevents its interaction with CD47, which potentially enhances macrophage-dependent anti-tumor activity (Journal for ImmunoTherapy of Cancer 2022, Vol 10: Suppl 2, 808). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DS-1103a | DS-1103a | 0 | 0 |
DS-1103a + Trastuzumab deruxtecan | DS-1103a Trastuzumab deruxtecan | 0 | 1 |